Pantoprazole Stada

Pantoprazole, the active ingredient in Pantoprazole Stada, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazole Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is used to manage acid‑related gastrointestinal disorders by decreasing gastric acid secretion.

- Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates healing of mucosal damage caused by acid reflux. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumours.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache - Diarrhoea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Acute interstitial nephritis - Bone fractures, especially with long‑term use - Liver enzyme abnormalities

When prescribing Pantoprazole, clinicians should consider several safety aspects.

- Assess the need for long‑term therapy: review periodically to determine whether the treatment is still necessary. - Monitor electrolyte levels: especially magnesium and calcium especially when the ​  - Evaluate the risk for osteoporosis and fracture if the ​  - Use the toral t t  d...

The